Literature DB >> 15690992

Comparisons of test statistics arising from marginal analyses of multivariate survival data.

Qian H Li1, Stephen W Lagakos.   

Abstract

We investigate the properties of several statistical tests for comparing treatment groups with respect to multivariate survival data, based on the marginal analysis approach introduced by Wei, Lin and Weissfeld ["Regression Analysis of multivariate incomplete failure time data by modelling marginal distributions," JASA vol. 84 pp. 1065-1073]. We consider two types of directional tests, based on a constrained maximization and on linear combinations of the unconstrained maximizer of the working likelihood function, and the omnibus test arising from the same working likelihood. The directional tests are members of a larger class of tests, from which an asymptotically optimal test can be found. We compare the asymptotic powers of the tests under general contiguous alternatives for a variety of settings, and also consider the choice of the number of survival times to include in the multivariate outcome. We illustrate the results with simulations and with the results from a clinical trial examining recurring opportunistic infections in persons with HIV.

Entities:  

Mesh:

Year:  2004        PMID: 15690992     DOI: 10.1007/s10985-004-4774-x

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  6 in total

1.  Power considerations for clinical trials using multivariate time-to-event data.

Authors:  M D Hughes
Journal:  Stat Med       Date:  1997-04-30       Impact factor: 2.373

2.  Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus.

Authors:  D D Richman; J M Grimes; S W Lagakos
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

3.  Cox regression analysis of multivariate failure time data: the marginal approach.

Authors:  D Y Lin
Journal:  Stat Med       Date:  1994-11-15       Impact factor: 2.373

4.  Risk of recurrent seizures after two unprovoked seizures.

Authors:  W A Hauser; S S Rich; J R Lee; J F Annegers; V E Anderson
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

5.  A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group.

Authors:  J O Kahn; S W Lagakos; D D Richman; A Cross; C Pettinelli; S H Liou; M Brown; P A Volberding; C S Crumpacker; G Beall
Journal:  N Engl J Med       Date:  1992-08-27       Impact factor: 91.245

6.  Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials Group.

Authors:  R Dolin; D A Amato; M A Fischl; C Pettinelli; M Beltangady; S H Liou; M J Brown; A P Cross; M S Hirsch; W D Hardy
Journal:  Arch Intern Med       Date:  1995-05-08
  6 in total
  1 in total

1.  Frailty, With or Without Cognitive Impairment, Is a Strong Predictor of Recurrent Falls in a US Population-Representative Sample of Older Adults.

Authors:  Mei-Ling Ge; Eleanor M Simonsick; Bi-Rong Dong; Judith D Kasper; Qian-Li Xue
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-10-13       Impact factor: 6.053

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.